Full Text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

This project employs artificial intelligence, including machine learning and deep learning, to assess COVID-19 readmission risk in Malaysia. It offers tools to mitigate healthcare resource strain and enhance patient outcomes. This study outlines a methodology for classifying COVID-19 readmissions. It starts with dataset description and pre-processing, while the data balancing was computed through Random Oversampling, Borderline SMOTE, and Adaptive Synthetic Sampling. Nine machine learning and ten deep learning techniques are applied, with five-fold cross-validation for evaluation. Optuna is used for hyperparameter selection, while the consistency in training hyperparameters is maintained. Evaluation metrics encompass accuracy, AUC, and training/inference times. Results were based on stratified five-fold cross-validation and different data-balancing methods. Notably, CatBoost consistently excelled in accuracy and AUC across all tables. Using ROS, CatBoost achieved the highest accuracy (0.9882 ± 0.0020) with an AUC of 1.0000 ± 0.0000. CatBoost maintained its superiority in BSMOTE and ADASYN as well. Deep learning approaches performed well, with SAINT leading in ROS and TabNet leading in BSMOTE and ADASYN. Decision Tree ensembles like Random Forest and XGBoost consistently showed strong performance.

Details

Title
Predictive Modeling of COVID-19 Readmissions: Insights from Machine Learning and Deep Learning Approaches
Author
Loo, Wei Kit 1 ; Voon, Wingates 2 ; Suhaimi, Anwar 3   VIAFID ORCID Logo  ; Cindy Shuan Ju Teh 4 ; Yee, Kai Tee 2   VIAFID ORCID Logo  ; Yan Chai Hum 2 ; Hasikin, Khairunnisa 1   VIAFID ORCID Logo  ; Teo, Kareen 1 ; Hang Cheng Ong 5 ; Khin Wee Lai 1   VIAFID ORCID Logo 

 Department of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, Kuala Lumpur 50603, Malaysia; [email protected] (W.K.L.); [email protected] (K.H.); [email protected] (K.T.) 
 Lee Kong Chian Faculty of Engineering and Science, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia; [email protected] (W.V.); [email protected] (Y.K.T.) 
 Department of Rehabilitation Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia; [email protected] 
 Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia; [email protected] 
 Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 56300, Malaysia; [email protected] 
First page
1511
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20754418
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3084795472
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.